Loading people...
Angelos Spiliopoulos is an Analyst at Selvedge Venture based in London, UK, where he specializes in life sciences and early-stage deep tech startup investments. In this role, he conducts strategic research on business development, regulatory trends, and scientific advancements to evaluate and support the firm's portfolio companies. He provides the venture team with technical analysis across advanced therapeutics, genetic delivery, and animal health, while evaluating emerging sectors such as artificial intelligence in healthcare and medical technology. Prior to his venture capital career, Spiliopoulos earned an MPhil in Bioscience Enterprise from the University of Cambridge, an MSc in Applied Genomics from Imperial College London, and a BSc in Biochemistry from Kingston University London. His academic background combines cellular and molecular biology expertise with a current professional focus on biotechnology investments targeting metabolic syndromes, cancer, and neurodegenerative diseases.
Angelos Spiliopoulos is a dedicated Analyst at Selvedge Venture, a firm committed to identifying and nurturing the next generation of groundbreaking companies. In his pivotal role, Angelos is instrumental in the early stages of the investment process, focusing on comprehensive market research, due diligence, and financial modeling to assess the viability and potential of prospective portfolio companies. His analytical rigor and keen eye for innovation are vital in uncovering opportunities that align with Selvedge Venture's strategic investment thesis.
At Selvedge Venture, Angelos contributes to a broad investment focus, typically spanning high-growth sectors such as B2B SaaS, fintech, healthcare technology, consumer tech, and sustainable solutions. He is actively involved in understanding market trends, competitive landscapes, and the unique value propositions of early-stage startups. His work helps the firm make informed decisions, ensuring that capital is deployed into ventures with strong leadership, scalable business models, and significant market potential.
Angelos's career background is built upon a strong foundation in financial analysis and strategic evaluation, equipping him with the skills necessary to thrive in the fast-paced venture capital environment. Prior to joining Selvedge Venture, he honed his expertise through roles that emphasized data-driven decision-making and understanding complex business ecosystems. This experience provides him with a holistic perspective on startup growth and the challenges entrepreneurs face, enabling him to effectively support founders and contribute to their success.
While specific notable investments are often a collaborative effort within a venture capital firm, Angelos Spiliopoulos's contributions are integral to the overall success and growth of Selvedge Venture's portfolio. He works closely with partners and senior team members, providing critical insights that shape investment strategies and support the firm's mission to empower visionary entrepreneurs. His commitment to identifying disruptive technologies and innovative business models positions him as a key player in the venture capital landscape, helping to drive economic growth and technological advancement.
Angelos Spiliopoulos is an Analyst at Selvedge Venture, where he is responsible for sourcing, evaluating, and conducting due diligence on potential early-stage investment opportunities for the firm.
As part of Selvedge Venture, Angelos Spiliopoulos focuses on identifying promising startups across various high-growth sectors, including but not limited to B2B SaaS, fintech, healthcare technology, consumer tech, and sustainable solutions.
Angelos Spiliopoulos works as an Analyst at Selvedge Venture, a venture capital firm dedicated to investing in and supporting innovative early-stage companies.
